Table 2. Costs and savings.

Present values (in billions of 2010 constant dollars) of annual AD-related M&M expenses and potential cost savings as estimated by Alzheimer’s Association (10) over 10-, 20-, and 30-year horizons under the current trajectory (CT) and two hypothetical scenarios: a delayed-onset trajectory (T2) and a slowed-progression trajectory (T3). A 10% nominal cost of capital and a 5% inflation rate were used to discount the real cost estimates.

Trajectory10-year
2015-2025
20-year
2015-2035
30-year
2015-2045
Current trajectory (CT)143627664250
Delayed onset (T2)122719612737
Slowed progression (T3)128022983438
(CT – T2)2088041513
(CT – T3)156468813